Harry Moultrie

Harry Moultrie

National Institute for Communicable Diseases - Johannesburg / South Africa
Others
AD Scientific Index ID: 4483133
Nasionale Instituut vir Oordraagbare Siektes
person_outline Harry Moultrie's MOST POPULAR ARTICLES
1-) Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South AfricaJRC Pulliam, C van Schalkwyk, N Govender, A von Gottberg, C Cohen, ...Science 376 (6593), eabn4947, 202210312022
2-) Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage studyN Wolter, W Jassat, S Walaza, R Welch, H Moultrie, M Groome, ...The Lancet 399 (10323), 437-446, 202210262022
3-) Effectiveness of BNT162b2 vaccine against omicron variant in South AfricaS Collie, J Champion, H Moultrie, LG Bekker, G GrayNew England Journal of Medicine 386 (5), 494-496, 20224702022
4-) Nevirapine versus ritonavir-boosted lopinavir for HIV-infected childrenA Violari, JC Lindsey, MD Hughes, HA Mujuru, L Barlow-Mosha, ...New England Journal of Medicine 366 (25), 2380-2389, 20122412012
5-) The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIVLF Johnson, K Stinson, ML Newell, RM Bland, H Moultrie, MA Davies, ...JAIDS Journal of Acquired Immune Deficiency Syndromes 59 (4), 417-425, 20122002012